Diabetic nephropathy in African Americans

被引:11
作者
Crook, ED
机构
[1] GV Sonny Montgomery VAMC, Jackson, MS 39211 USA
[2] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
关键词
African American; diabetic nephropathy; angiotensin-converting enzyme inhibitors; end-stage renal disease; hypertension;
D O I
10.1016/S0895-7061(01)02080-5
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Diabetic nephropathy (DN) is the number one cause of end-stage renal disease in United States and is highly prevalent in African Americans. We have found that among African Americans in Mississippi diabetic nephropathy appears to affect females more than males, which may be related to increased rates of obesity and diabetes in African American women. Glycemic control and control of blood pressure is essential to prolong renal survival and to protect against cardiovascular events. Angiotensin-converting enzyme inhibitors reduce cardiovascular mortality in diabetics and are tolerated in advanced renal disease. The impact of glycemic control, appropriate antihypertensives, and the optimal level of blood pressure control in African Americans with advanced DN require further study. This article reviews the impact, clinical characteristics, risk factors, and treatment of diabetic nephropathy in African Americans. Am J Hypertens 2001; 14:132S-138S (C) 2001 American Journal of Hypertension, Ltd.
引用
收藏
页码:132S / 138S
页数:7
相关论文
共 63 条
[1]   Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes [J].
Abbott, K ;
Smith, A ;
Bakris, GL .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (03) :274-279
[2]   Genes within and flanking the major histocompatibility region are risk factors for diabetes, insulin resistance, hypertension, and microalbuminuria in African-American women [J].
Acton, RT ;
Bell, DSH ;
Collins, J ;
Giger, JN ;
Go, RCP ;
Harrison, R ;
McDonald, R ;
Rivers, C ;
Roseman, JM ;
Taylor, HA ;
Vanichanan, C .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (08) :3710-3712
[3]  
Agodoa Lawrence, 1998, Ethnicity and Disease, V8, P249
[4]   Barriers to cadaveric renal transplantation among blacks, women, and the poor [J].
Alexander, GC ;
Sehgal, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (13) :1148-1152
[5]  
[Anonymous], USRDS 1999 ANN DAT R
[6]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[7]   Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury [J].
Bakris, GL ;
Griffin, KA ;
Picken, MM ;
Bidani, AK .
JOURNAL OF HYPERTENSION, 1997, 15 (10) :1181-1185
[8]   Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern? [J].
Bakris, GL ;
Weir, MR .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) :685-693
[9]   Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans [J].
Bakris, GL ;
Mangrum, A ;
Copley, JB ;
Vicknair, N ;
Sadler, R .
HYPERTENSION, 1997, 29 (03) :744-750
[10]   Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy [J].
Bakris, GL ;
Copley, JB ;
Vicknair, N ;
Sadler, R ;
Leurgans, S .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1641-1650